enGene Therapeutics ENGN
NASDAQ ENGN
$1.98 -0.02 (-1.00%)
At close: Oct 1, 2026 · 4:00 PM EDT

enGene Therapeutics (ENGN) Accumulated Depreciation (2022 - 2026)

Updated

enGene Therapeutics' Accumulated Depreciation was $2.63 million in fiscal Q3 2026 (quarter ended Jul 31, 2026), up 36.3% from $1.93 million a year earlier and up 7.3% from the prior quarter.

Analysis

enGene Therapeutics (ENGN) Accumulated Depreciation (2022 - 2026) Analysis & Trends

At the end of FY2025 (ended Oct 31, 2025), Accumulated Depreciation at enGene Therapeutics came in at $2.1 million, up 30.6% from FY2024.

  • Accumulated Depreciation shows a three-year compound annual growth rate of 10.6% (FY2022 to FY2025).
  • In earlier fiscal years, Accumulated Depreciation was $1.61 million in FY2024 (-6.8%), $1.73 million in FY2023 (+11.2%) and $1.55 million in FY2022.
  • The fiscal Q3 2026 figure marks the highest quarterly Accumulated Depreciation in data going back to fiscal Q4 2022.
  • Compared with a year earlier, Accumulated Depreciation has increased for five straight quarters, with growth averaging 18.3% over the last eight quarters.
  • The best year-over-year quarter for Accumulated Depreciation over five years was fiscal Q3 2026 (growth of 36.3%); the worst was fiscal Q4 2024 (a decline of 6.8%).
  • Per Business Quant data, ENGN's Accumulated Depreciation in the three fiscal quarters before Q3 2026 was $2.46 million (Q2 2026), $2.29 million (Q1 2026) and $2.1 million (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 enGene Therapeutics 134.03 Mn 134.03 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jul 31, 2026 2.63 Mn
Apr 30, 2026 2.46 Mn
Jan 31, 2026 2.29 Mn
Oct 31, 2025 2.10 Mn
Jul 31, 2025 1.93 Mn
Apr 30, 2025 1.82 Mn
Jan 31, 2025 1.71 Mn
Oct 31, 2024 1.61 Mn
Jul 31, 2024 1.53 Mn
Apr 30, 2024 1.89 Mn
Jan 31, 2024 1.81 Mn
Oct 31, 2023 1.73 Mn
Oct 31, 2022 1.55 Mn
API Access

enGene Therapeutics Accumulated Depreciation API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=accumulated-depreciation&ticker=ENGN&period=max&api_key=YOUR_API_KEY